Sign in

    Timothy C. Wentworth

    Chief Executive Officer at Walgreens Boots Alliance Inc
    Board
    Since October 23, 2023
    Age
    64 years
    Education
    Holds an associate’s degree in business from Monroe Community College and a bachelor’s degree in industrial and labor relations from Cornell University.
    Tenure
    Joined WBA on October 23, 2023 as Chief Executive Officer and serves on the board of directors.

    Also at Walgreens Boots Alliance Inc

    BL
    Beth Leonard
    Senior Vice President and Chief Corporate Affairs Officer
    EB
    Elizabeth Burger
    Executive Vice President and Chief Human Resources Officer
    LM
    Lanesha Minnix
    Executive Vice President and Global Chief Legal Officer

    About

    Timothy C. Wentworth, born in 1959 and currently 64 years old, has built a robust foundation through his academic achievements. He holds an associate’s degree in business from Monroe Community College and earned a bachelor’s degree in industrial and labor relations from Cornell University.

    Throughout his extensive career, he has held influential leadership positions in major organizations such as PepsiCo, Mary Kay, Medco Health Solutions, and Express Scripts, where his guidance helped transform the company into a Fortune 22 entity with over $100 billion in revenue and 26,000 employees.

    Since joining WBA on October 23, 2023, he assumed the role of Chief Executive Officer and became a member of the board of directors, driving strategic initiatives to enhance operational performance and create greater value for shareholders, patients, and employees.

    $WBA Performance Under Timothy C. Wentworth

    Past Roles

    Organization Role Date Range Details
    The Cigna Group CEO, Evernorth Health Services September 2020 - December 2021 Role held immediately prior to joining WBA
    The Cigna Group President, Health Services February 2020 - December 2021 Concurrent role with Evernorth health services leadership
    The Cigna Group President, Express Scripts and Cigna Services December 2018 - February 2020 Oversaw integrated healthcare services
    Express Scripts, Inc. CEO May 2016 - December 2018 Led the company through strategic initiatives
    Express Scripts, Inc. Various Management Positions April 2012 - May 2016 Held multiple leadership roles

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary $1,500,000AnnualFixed annualized base salary; subject to future adjustments by the CLP Committee
    Relocation Benefits Not utilized in 2024N/ABenefits eligible to induce his hire; no usage during fiscal 2024
    Corporate Aircraft Usage $179,394Fiscal Year UsagePersonal use up to 75 hours per fiscal year; incremental cost incurred in 2024
    Executive Severance and Change in Control Plan N/AN/ACovered under the plan in the event of termination or change in control; no specific dollar amount provided

    Performance Compensation

    Data from  FY 2024

    Annual Bonus

    MetricDetails
    Target Bonus$3,000,000 (200% of base salary)
    Threshold50% of target: $1,500,000
    Maximum Award200% of target: $6,000,000
    Performance GoalsBased on pre-established financial and non-financial objectives under the Management Incentive Plan (MIP)
    Individual Performance FactorAdjustable by up to +20% or down by up to 100% based on individual performance
    ProrationBonus prorated due to Mr. Wentworth's start date on October 23, 2023

    Long-Term Incentives

    MetricDetails
    Initial Grant Value$12,000,000 (grant date value)
    Grant Composition50% Performance Stock Units (PSUs) and 50% Restricted Stock Units (RSUs)
    Vesting ScheduleVest over three years; RSUs vest in one-third increments on the first, second, and third anniversaries of the grant date
    Performance Metrics for PSUsTied to adjusted EPS growth and revenue growth performance; specific thresholds/targets not detailed
    Other ConditionsAwards subject to forfeiture in certain circumstances or accelerated vesting upon retirement
    Grant Date Stock PriceNot applicable/unspecified

    No further detailed quantitative performance metrics such as exact performance thresholds, weights, or evaluation period specifics are available for 2024.